Thalidomide in Treating Patients With Myelodysplastic Syndrome
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of thalidomide in treating patients who have
myelodysplastic syndrome. Thalidomide may improve the immune system's ability to fight
myelodysplastic syndrome